Bio-Rad Laboratories Inc.

02/21/2024 | Press release | Distributed by Public on 02/21/2024 16:12

Regulation FD Disclosure - Form 8-K

ITEM 7.01 Regulation FD Disclosure.

Bio-Rad Laboratories, Inc. ("Bio-Rad") hereby provides the following update on information disclosed under the heading "Investment in Sartorius AG" in Part 1 Item 1 of Bio-Rad's Form 10-K for the year ended December 31, 2023 that was filed on February 16, 2024 relating to Bio-Rad's investment in Sartorius AG. The update relates to Sartorius AG's financial results for the year ended December 31, 2023 that were disclosed by Sartorius AG on February 16, 2024.

Investment in Sartorius AG

The following summarizes certain financial data of Sartorius as of and for the year ended December 31, 2023, (in millions).
December 31, 2023 (1)
Current assets € 1,956.9
Non-current assets 7,798.5
Current liabilities 1,330.0
Non-current liabilities 5,667.9
Equity 2,757.4
Year Ended December 31, 2023 (1)
Sales revenue € 3,395.7
Gross profit on sales 1,567.1
Earnings before interest and taxes (EBIT) 503.9
Net profit 290.0
Cash flow from operating activities 853.6
Cash flow from investing activities (2,823.3)
Cash flow from financing activities 2,165.7

1.As disclosed in Sartorius AG's consolidated financial statements for the year ended December 31, 2023, prepared in accordance with the International Financial Reporting Standards (IFRS), the International Financial Reporting Interpretations Committee (IFRIC) Standards, and the International Accounting Standards Board (IASB) as required to be applied by the European Union, and based upon information publicly disclosed by Sartorius. Bio-Rad does not assume, and by way of referencing the financial data of Sartorius above shall not be deemed to assume, any responsibility or liability for any errors or omissions in the information publicly disclosed by Sartorius.

Refer to Sartorius' 2023 Annual Report for further details, which can be found at The Sartorius website and any information disclosed thereon are not incorporated by reference into this report.